Big Move For Avid Bioservices, Inc.
Tue, Mar 14, 2023 at 07:09 PM
Avid Bioservices, Inc. (CDMO:NASDAQ) shot up at $18.79, representing a gain of 36%. On Tue, Mar 14, 2023, CDMO:NASDAQ hit a New 2-Week High of $18.79. The stock got featured on our News Catalysts scanner on Mon, Mar 13, 2023 at 05:41 PM in the 'EARNINGS' category. From Tue, Feb 28, 2023, the stock recorded 20.00% Up Days and 45.45% Green Days
About Avid Bioservices, Inc. (CDMO:NASDAQ)
Peregrine Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It develops novel investigational products that help utilize the immune system to fight cancer, also known as immunotherapy.
Top 10 Gainers:
- Ambipar Emergency Response Class A (AMBI:NYSEMKT), 116.81%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 64.84%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 54.17%
- Metropolitan Bank Holding Corp. (MCB:NYSE), 38.98%
- Mmtec, Inc. (MTC:NASDAQ), 38.93%
- Lavoro Limited (LVRO:NASDAQ), 37.77%
- SOPHiA GENETICS SA (SOPH:NASDAQ), 37.47%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 36.44%
- Avid Bioservices, Inc. (CDMO:NASDAQ), 35.96%
- PacWest Bancorp (PACW:NASDAQ), 33.85%